Jeff Cerny
Analyst · Barclays. Please go ahead
Thanks, Bilal. Turning to our first quarter results, our investment portfolio totaled $316.2 million on a fair value basis as of March 31, equating to 99.7% of cost. Looking at where the portfolio stood at March 31, the portfolio is comprised of 60 companies including 26 in the SBIC fund. As a percentage of fair value at quarter-end, our investments were comprised of approximately 73% in senior secured loans, 20% in subordinated debt, and 7% in equity. At March 31, the 60 companies in our portfolio were diversified across 19 industries. Our largest portfolio company accounted for 4.6% of the aggregate fair value of our portfolio. Our five largest investments accounted for approximately 22% of the portfolio’s total fair value. Our average investment in each portfolio company was $5.3 million at fair value or 1.67% of the portfolio’s total fair value. The weighted average yield to fair value was 6.8% on debt investments in our senior loan fund and 12.1% on debt investments in our SBIC fund. The overall weighted average yield to fair value on our debt investments continues to move in a positive direction. It increased 68 basis points since last quarter from 9.56% to 10.24%. The 68 basis point pickup in weighted average yield to fair value quarter-over-quarter reflects the continued ramp up in our SBIC fund and pay downs in our senior loan fund. On a fair value basis at March 31, the debt investments in the SBIC fund now represent approximately 64% of the overall debt portfolio versus 60% last quarter. As Bilal mentioned, our intention is to continue to fully ramp up our SBIC fund and redeploy capital from our senior loan fund into higher yielding assets. Our one non-accrual investment was omitted from the weighted average yield to fair value calculation. At the end of the first quarter, floating rate loans comprised 70% of our loan portfolio. This is down from 73% last quarter largely driven by the growth in our SBIC portfolio. The SBIC portfolio, include certain unit tranche and subordinated debt investments that tend to be structured with fixed rates. All of our floating rate loans contain LIBOR floors. As I noted earlier, we had one non-accrual at March 31, Strata Pathology Services. It had a fair value of $713,000 and has been on non-accrual since the first quarter of 2013. Moving on to deal activity, during the first quarter, we closed five transactions with portfolio companies in an aggregate principal amount of $24.8 million. This included $18 million of investments in three new portfolio companies and $6.8 million of follow-on investments in two portfolio companies. These investments included senior secured loans, subordinated loans and preferred stock with approximately 92% constituting loan investments. We derived approximately $7.6 million in total investment income in the first quarter, compared to $6.9 million in the fourth quarter. This 10% improvement quarter-over-quarter was largely due to achieving a full quarter of interest income from investments closed during the fourth quarter, as well as the new first quarter investments, and a 68 basis point increase in the weighted average yield to fair value quarter-over-quarter, reflecting our stated goal of shifting away from the senior loan fund. Approximately $1.9 million of the first quarter's total investment income was derived from our senior loan fund and $5.7 million came from our SBIC fund. The percentage of total investment income derived from the SBIC fund was 75% versus 67% in the prior quarter. Again, these highlights our efforts to optimize our portfolio into higher yielding investments. Expenses totaled $4.9 million for the first quarter, compared to $4.2 million for the prior quarter. The $700,000 increase in expenses was largely driven by our management fees returning to contractual level, plus a seasonal increase in our administrative feeder in the first quarter. It is important to know that there is a $430,000 non-cash right-off of deferred financing closing cost related to our voluntary commitment reduction of our senior loan fund debt facility versus $665,000 last quarter. This reduction was initiated to eliminate fees on the unused portion of our line of credit that was not needed as we shrink the senior loan fund portfolio. Net investment income for the first quarter was approximately $2.7 million or $0.28 per share, which was unchanged from the prior quarter. Our adjusted net investment income was $2.8 million or $0.29 per share, excluding the non-cash write-off of $430,000 but adding back $336,000 in additional incentive fees we would have paid in the absence of the write-off. We believe this adjusted net investment income of $0.29 per share, which is a non-GAAP measure, provides greater transparency and insight into our ongoing operations. We expect to continue presenting this non-GAAP adjusted net investment income amount in the future as we are likely to incur additional non-cash charges related to further reductions of our senior loan fund debt facility. The facility reductions will be determined as we continue our efforts to shift our capital towards reporting higher yielding investments. As of March 31, we had $1.3 million of deferred financing closing cost related to the senior loan fund debt facility on our books. The unamortized portion of the $1.3 million that remains upon the full repayment and cancellation of our senior loan fund debt facility will be written off. For the first quarter, we had a net increase in net assets resulting from operations of $3.2 million or $0.33 per share compared with $3.5 million or $0.36 per share for the fourth quarter. Turning to our capacity to make additional investments, as of March 31, our existing SBIC fund had approximately $23 million in liquidity, which included $9 million in incremental SBA debenture borrowing capacity. As Bilal just described, we have several other liquidity options, including the redeployment of capital from out senior loan fund. Our goal is to prudently generate liquidity on a timeline that allows us to maximize our interest income, only selling lower yielding assets or otherwise generating capital when we believe we can timely redeploy the cash. With that, I will turn the call back over the Bilal.